Trial intelligence / Profile preview

EEG Profiles of Remimazolam vs Propofol in General Anesthesia

NCT05533567Unknown

Sponsor
The Second Affiliated Hospital of Nanchang University
Start
Oct 2022
Primary completion
Jan 2023
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of remimazolam in general anesthesia (2 arms), sponsored by The Second Affiliated Hospital of Nanchang University. Primary endpoint: Electroencephalographic waveforms at 2 hours. Status: unknown.

02

Drugs

remimazolam
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT05533567.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05533567.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call